2023 Q1 Form 10-K Financial Statement

#000149315223010222 Filed on March 31, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $9.848M $12.21M $45.84M
YoY Change -8.68% 35.01% 33.19%
Cost Of Revenue $6.763M $9.194M $31.97M
YoY Change -3.0% 35.01% 38.89%
Gross Profit $3.085M $3.013M $13.87M
YoY Change -19.07% 34.98% 21.69%
Gross Profit Margin 31.33% 24.68% 30.25%
Selling, General & Admin $1.744M $1.605M $6.403M
YoY Change 25.1% -17.84% 14.92%
% of Gross Profit 56.52% 53.26% 46.17%
Research & Development $21.50K $35.93K $99.28K
YoY Change 21.51% -45.37% -14.72%
% of Gross Profit 0.7% 1.19% 0.72%
Depreciation & Amortization $302.8K $465.6K $1.104M
YoY Change 60.75% 82.31% 42.69%
% of Gross Profit 9.82% 15.45% 7.96%
Operating Expenses $1.903M $1.640M $6.818M
YoY Change 28.5% -18.74% 15.31%
Operating Profit $1.182M $1.372M $7.050M
YoY Change -49.28% 543.56% 28.58%
Interest Expense $134.9K $55.42K $292.9K
YoY Change 134.08% -334.53% -18.65%
% of Operating Profit 11.41% 4.04% 4.16%
Other Income/Expense, Net
YoY Change
Pretax Income $1.264M $1.428M $7.859M
YoY Change -47.1% 510.28% 18.17%
Income Tax $299.8K -$1.459M $145.9K
% Of Pretax Income 23.71% -102.16% 1.86%
Net Earnings $884.4K $2.718M $7.022M
YoY Change -42.31% -897.55% 103.57%
Net Earnings / Revenue 8.98% 22.27% 15.32%
Basic Earnings Per Share $0.07 $0.57
Diluted Earnings Per Share $0.07 $0.22 $0.56
COMMON SHARES
Basic Shares Outstanding 12.44M shares 12.38M shares 12.38M shares
Diluted Shares Outstanding 12.53M shares 12.47M shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.530M $6.115M $6.115M
YoY Change 2.95% 7.09% 7.09%
Cash & Equivalents $5.530M $6.815M $6.115M
Short-Term Investments
Other Short-Term Assets $1.332M $1.010M $1.010M
YoY Change -29.36% -31.16% -31.16%
Inventory $14.38M $14.42M $14.42M
Prepaid Expenses $331.8K $310.3K
Receivables $10.83M $9.450M $9.450M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $32.08M $30.99M $30.99M
YoY Change 9.05% 30.18% 30.18%
LONG-TERM ASSETS
Property, Plant & Equipment $9.620M $9.709M $9.877M
YoY Change 95.52% 96.87% 91.81%
Goodwill $2.534M $2.534M
YoY Change 0.0% 0.0%
Intangibles $2.400M $2.440M
YoY Change -6.25% -6.15%
Long-Term Investments $5.529M $5.459M $5.467M
YoY Change 1.39% 0.64% 0.64%
Other Assets $274.3K $274.3K $274.3K
YoY Change 2059.76% 2059.76% 2059.76%
Total Long-Term Assets $20.86M $20.59M $20.59M
YoY Change 32.87% 30.81% 30.81%
TOTAL ASSETS
Total Short-Term Assets $32.08M $30.99M $30.99M
Total Long-Term Assets $20.86M $20.59M $20.59M
Total Assets $52.94M $51.59M $51.59M
YoY Change 17.34% 30.43% 30.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.473M $873.9K $873.9K
YoY Change 8.1% -31.91% -31.91%
Accrued Expenses $181.4K $959.9K $1.018M
YoY Change -86.24% 110.01% 90.35%
Deferred Revenue
YoY Change
Short-Term Debt $3.664M $2.819M $2.819M
YoY Change -25.97% 22.5% 22.5%
Long-Term Debt Due $719.6K $717.6K $717.6K
YoY Change 8.11% -9.57% -9.57%
Total Short-Term Liabilities $10.85M $10.30M $10.30M
YoY Change -21.93% 4.88% 4.88%
LONG-TERM LIABILITIES
Long-Term Debt $5.257M $5.436M $5.436M
YoY Change 252.49% 245.61% 245.61%
Other Long-Term Liabilities $96.01K $109.1K $109.1K
YoY Change -34.54% -21.79% -21.79%
Total Long-Term Liabilities $5.257M $5.436M $5.546M
YoY Change 252.49% 245.61% 223.82%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.85M $10.30M $10.30M
Total Long-Term Liabilities $5.257M $5.436M $5.546M
Total Liabilities $16.70M $16.35M $18.95M
YoY Change 5.41% 38.01% 31.18%
SHAREHOLDERS EQUITY
Retained Earnings $16.79M $15.90M
YoY Change 61.19% 79.05%
Common Stock $12.44K $12.43K
YoY Change 0.47% 0.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $33.55M $32.63M $32.63M
YoY Change
Total Liabilities & Shareholders Equity $52.94M $51.59M $51.59M
YoY Change 17.34% 30.43% 30.43%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income $884.4K $2.718M $7.022M
YoY Change -42.31% -897.55% 103.57%
Depreciation, Depletion And Amortization $302.8K $465.6K $1.104M
YoY Change 60.75% 82.31% 42.69%
Cash From Operating Activities -$228.2K $2.135M $1.477M
YoY Change -90.59% 784.57% -67.44%
INVESTING ACTIVITIES
Capital Expenditures $213.1K $1.334M $1.981M
YoY Change 20.59% -878.98% 153.29%
Acquisitions $499.3K
YoY Change
Other Investing Activities -$342.8K $156.2K -$234.3K
YoY Change -4670.0% -57.79% -291.01%
Cash From Investing Activities -$555.8K -$1.178M -$2.216M
YoY Change 228.52% -692.11% 235.94%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $140.6K
YoY Change 0.13%
Debt Paid & Issued, Net $177.6K $2.293M
YoY Change -15.26% 143.12%
Cash From Financing Activities $666.4K 1.519M $848.3K
YoY Change -69.89% 358.62% -149.62%
NET CHANGE
Cash From Operating Activities -$228.2K 2.135M $1.477M
Cash From Investing Activities -$555.8K -1.178M -$2.216M
Cash From Financing Activities $666.4K 1.519M $848.3K
Net Change In Cash -$284.9K 2.476M $79.53K
YoY Change -15.86% 220.98% -96.49%
FREE CASH FLOW
Cash From Operating Activities -$228.2K $2.135M $1.477M
Capital Expenditures $213.1K $1.334M $1.981M
Free Cash Flow -$441.3K $801.4K -$504.4K
YoY Change -83.04% 94.19% -113.44%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001069394
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
A0
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
A0
CY2022 FSI Paycheck Protection Program Loan Forgiveness
PaycheckProtectionProgramLoanForgiveness
usd
CY2022 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
usd
CY2021 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
usd
CY2022 us-gaap Proceeds From Sale Of Other Property Plant And Equipment
ProceedsFromSaleOfOtherPropertyPlantAndEquipment
usd
CY2022Q4 FSI Finite Lived Patent Gross
FiniteLivedPatentGross
usd
CY2022 FSI Gain Loss On Sale Of Land
GainLossOnSaleOfLand
usd
CY2022 FSI Ppp Loan Forgiveness
PppLoanForgiveness
usd
CY2021 FSI Gain On Acquisition
GainOnAcquisition
usd
CY2022 FSI Gain Loss On Sale Of Land
GainLossOnSaleOfLand
usd
CY2021 FSI Gain On Acquisition Of Subsidiary
GainOnAcquisitionOfSubsidiary
usd
CY2021 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
usd
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
usd
CY2021 us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
usd
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
usd
CY2021 FSI Proceeds From Loan Acquired From Acquisition
ProceedsFromLoanAcquiredFromAcquisition
usd
CY2022 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
usd
CY2021 FSI Income Tax Recovery
IncomeTaxRecovery
usd
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
23809069 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9709288 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4931713 usd
CY2022 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
usd
CY2021 FSI Current Income Tax Expense
CurrentIncomeTaxExpense
usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-31540
CY2022 dei Entity Registrant Name
EntityRegistrantName
FLEXIBLE SOLUTIONS INTERNATIONAL, INC.
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
71-1630889
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
6001 54 Ave.
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Taber
CY2022 dei Entity Address Country
EntityAddressCountry
CA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
T1G 1X4
CY2022 dei City Area Code
CityAreaCode
(403)
CY2022 dei Local Phone Number
LocalPhoneNumber
223-2995
CY2022 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
CY2022 dei Trading Symbol
TradingSymbol
FSI
CY2022 dei Security Exchange Name
SecurityExchangeName
NYSEAMER
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
19343103 usd
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12435532 shares
CY2022 dei Auditor Firm
AuditorFirmId
995
CY2022 dei Auditor Name
AuditorName
Smythe LLP
CY2022 dei Auditor Location
AuditorLocation
Vancouver, Canada
CY2022Q4 us-gaap Cash
Cash
6115099 usd
CY2021Q4 us-gaap Cash
Cash
5710227 usd
CY2022Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
700000 usd
CY2021Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
1025347 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9449857 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7129329 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
14419430 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
9502005 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
310297 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
442161 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
30994683 usd
CY2021Q4 FSI Finite Lived Patent Gross
FiniteLivedPatentGross
13699 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
167222 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
217267 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2440000 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2600000 usd
CY2022Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
8540 usd
CY2021Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
8540 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
5458895 usd
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
5424010 usd
CY2022Q4 us-gaap Goodwill
Goodwill
2534275 usd
CY2021Q4 us-gaap Goodwill
Goodwill
2534275 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
274289 usd
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
12697 usd
CY2022Q4 us-gaap Assets
Assets
51587192 usd
CY2021Q4 us-gaap Assets
Assets
39551270 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
873904 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1283486 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
959856 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
457062 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
387763 usd
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
349004 usd
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
4486350 usd
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
4561396 usd
CY2022Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
2818591 usd
CY2021Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
2300819 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
58080 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
77715 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
717612 usd
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
793574 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10302156 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
9823056 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
109142 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
139552 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
500459 usd
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
310162 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5436465 usd
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1573024 usd
CY2022Q4 us-gaap Liabilities
Liabilities
16348222 usd
CY2021Q4 us-gaap Liabilities
Liabilities
11845794 usd
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12426260 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12426260 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12355246 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12355246 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
12426 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
12355 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
12426 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
12355 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
17523345 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
16983648 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-805799 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-775730 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
15903964 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
8882360 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
32633936 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
25102633 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
2605034 usd
CY2021Q4 us-gaap Minority Interest
MinorityInterest
2602843 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
35238970 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
27705476 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
51587192 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
39551270 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
45840469 usd
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34416335 usd
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
31971596 usd
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
23019824 usd
CY2022 us-gaap Gross Profit
GrossProfit
13868873 usd
CY2021 us-gaap Gross Profit
GrossProfit
11396511 usd
CY2022 us-gaap Salaries And Wages
SalariesAndWages
2537783 usd
CY2021 us-gaap Salaries And Wages
SalariesAndWages
2321285 usd
CY2022 us-gaap Officers Compensation
OfficersCompensation
1032394 usd
CY2021 us-gaap Officers Compensation
OfficersCompensation
883460 usd
CY2022 us-gaap General Insurance Expense
GeneralInsuranceExpense
683272 usd
CY2021 us-gaap General Insurance Expense
GeneralInsuranceExpense
581187 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
660821 usd
CY2021 us-gaap Professional Fees
ProfessionalFees
285424 usd
CY2022 us-gaap Other General Expense
OtherGeneralExpense
350126 usd
CY2021 us-gaap Other General Expense
OtherGeneralExpense
269459 usd
CY2022 FSI Consulting
Consulting
312171 usd
CY2021 FSI Consulting
Consulting
320759 usd
CY2022 us-gaap Interest Expense
InterestExpense
292949 usd
CY2021 us-gaap Interest Expense
InterestExpense
199930 usd
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
182609 usd
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
172185 usd
CY2022 FSI Investor Relations And Transfer Agent Fee
InvestorRelationsAndTransferAgentFee
179505 usd
CY2021 FSI Investor Relations And Transfer Agent Fee
InvestorRelationsAndTransferAgentFee
94256 usd
CY2022 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
171369 usd
CY2021 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
107894 usd
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
149446 usd
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
382663 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
99275 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
116411 usd
CY2022 us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
42098 usd
CY2021 us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
45482 usd
CY2022 FSI Commissions
Commissions
30732 usd
CY2021 FSI Commissions
Commissions
62632 usd
CY2022 us-gaap Utilities Operating Expense
UtilitiesOperatingExpense
29517 usd
CY2021 us-gaap Utilities Operating Expense
UtilitiesOperatingExpense
21523 usd
CY2022 FSI Shipping Cost
ShippingCost
23469 usd
CY2021 FSI Shipping Cost
ShippingCost
16567 usd
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-23091 usd
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-25091 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
17869 usd
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
6979 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
6818496 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
5913187 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
7050377 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
5483324 usd
CY2021 FSI Gain Loss On Sale Of Land
GainLossOnSaleOfLand
44330 usd
CY2021 FSI Ppp Loan Forgiveness
PppLoanForgiveness
537960 usd
CY2022 us-gaap Gain Loss On Investments
GainLossOnInvestments
341424 usd
CY2021 us-gaap Gain Loss On Investments
GainLossOnInvestments
507143 usd
CY2022 FSI Gain On Acquisition
GainOnAcquisition
335051 usd
CY2022 us-gaap Interest Income Other
InterestIncomeOther
132233 usd
CY2021 us-gaap Interest Income Other
InterestIncomeOther
77999 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7859085 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6650756 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-71295 usd
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
363317 usd
CY2022 FSI Current Income Tax Expense Benefits
CurrentIncomeTaxExpenseBenefits
217151 usd
CY2021 FSI Current Income Tax Expense Benefits
CurrentIncomeTaxExpenseBenefits
1993182 usd
CY2022 us-gaap Profit Loss
ProfitLoss
7713229 usd
CY2021 us-gaap Profit Loss
ProfitLoss
4294257 usd
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
691625 usd
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
845095 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
7021604 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
3449162 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.57
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.28
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.28
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12379316 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12316254 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12466415 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12505522 shares
CY2022 us-gaap Profit Loss
ProfitLoss
7713229 usd
CY2021 us-gaap Profit Loss
ProfitLoss
4294257 usd
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-30069 usd
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
96391 usd
CY2022 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
7683160 usd
CY2021 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
4390648 usd
CY2022 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
691625 usd
CY2021 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
845095 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6991535 usd
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3545553 usd
CY2022 us-gaap Profit Loss
ProfitLoss
7713229 usd
CY2021 us-gaap Profit Loss
ProfitLoss
4294257 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
399148 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
210112 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1277431 usd
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
965935 usd
CY2022 FSI Lease Right Of Use Financing
LeaseRightOfUseFinancing
8566 usd
CY2021 FSI Lease Right Of Use Financing
LeaseRightOfUseFinancing
22057 usd
CY2022 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
50045 usd
CY2021 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
265846 usd
CY2022 us-gaap Gain Loss On Investments
GainLossOnInvestments
341424 usd
CY2021 us-gaap Gain Loss On Investments
GainLossOnInvestments
507143 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
17869 usd
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
6979 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-71295 usd
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
363317 usd
CY2021 FSI Gain Loss On Sale Of Land
GainLossOnSaleOfLand
44330 usd
CY2022 FSI Gain On Acquisition Of Subsidiary
GainOnAcquisitionOfSubsidiary
335051 usd
CY2021 FSI Paycheck Protection Program Loan Forgiveness
PaycheckProtectionProgramLoanForgiveness
537960 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2338397 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1246495 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4124022 usd
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1275746 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-131864 usd
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
139714 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-700191 usd
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
102856 usd
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-249628 usd
CY2021 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
2021048 usd
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
38759 usd
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
34727 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1476903 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4535746 usd
CY2021 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
500000 usd
CY2022 us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
265001 usd
CY2021 us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
359300 usd
CY2022 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
499329 usd
CY2021 us-gaap Proceeds From Sale Of Other Property Plant And Equipment
ProceedsFromSaleOfOtherPropertyPlantAndEquipment
263380 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1981307 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
782219 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2215635 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-659539 usd
CY2022 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
517772 usd
CY2021 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
184746 usd
CY2022 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2292819 usd
CY2021 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
943080 usd
CY2022 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
3230798 usd
CY2022 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
58611 usd
CY2021 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
287903 usd
CY2022 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
689434 usd
CY2021 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
804003 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
140620 usd
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
140440 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
848326 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1709800 usd
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-30069 usd
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
96391 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
79525 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2262798 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6735574 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4472776 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6815099 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6735574 usd
CY2022Q4 us-gaap Cash
Cash
6115099 usd
CY2021Q4 us-gaap Cash
Cash
5710227 usd
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
700000 usd
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
1025347 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6815099 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6735574 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
158966 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
292949 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
179029 usd
CY2022 FSI Inventory Additions In Accounts Payable And Accrued Liabilities
InventoryAdditionsInAccountsPayableAndAccruedLiabilities
793403 usd
CY2021 FSI Inventory Additions In Accounts Payable And Accrued Liabilities
InventoryAdditionsInAccountsPayableAndAccruedLiabilities
250923 usd
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
23768279 usd
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
96391 usd
CY2021 us-gaap Profit Loss
ProfitLoss
4294257 usd
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
140440 usd
CY2021 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
804003 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
210112 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
27705476 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
27705476 usd
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-30069 usd
CY2022 us-gaap Profit Loss
ProfitLoss
7713229 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
140620 usd
CY2022 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
689434 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
399148 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
35238970 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
35238970 usd
CY2022Q4 us-gaap Deposits
Deposits
700000 usd
CY2022Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.030 pure
CY2022Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
150 usd
CY2022Q4 FSI Other Term Deposit
OtherTermDeposit
300000 usd
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_846_eus-gaap--ConcentrationRiskCreditRisk_z7zMXGIcafY9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q) <i><span id="xdx_863_zfVzWjpTjH75">Risk Management</span>.</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s credit risk is primarily attributable to its accounts receivable. The amounts presented in the accompanying consolidated balance sheets are net of allowances for doubtful accounts, estimated by the Company’s management based on prior experience and the current economic environment. The Company is exposed to credit-related losses in the event of non-payment by customers. Credit exposure is minimized by dealing with only credit worthy counterparties. Revenue for the Company’s three primary customers totaled $<span id="xdx_905_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember_zzsCVFT5YIm5" title="Sales">27,775,617</span> (<span id="xdx_90F_ecustom--ConcentrationRiskThresholdPercentage_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_z0EDxo9FgWEl" title="Accounts receivable, after allowance for credit loss">61</span>%) for the year ended December 31, 2022 (2021 - $<span id="xdx_90D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember_zuRfBH2lIaQ5" title="Sales">16,917,947</span> or <span id="xdx_90F_ecustom--ConcentrationRiskThresholdPercentage_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zwe1PI7n21j" title="Accounts receivable, after allowance for credit loss">49</span>%). Accounts receivable for the Company’s three primary customers totaled $<span id="xdx_904_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember_z0Glx4WSJjMl" title="Accounts receivable, after allowance for credit loss">6,124,424</span> (<span id="xdx_907_ecustom--ConcentrationRiskThresholdPercentage_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zwBakjUGHaxf" title="Accounts receivable, after allowance for credit loss, percentage">65</span>%) at December 31, 2022 (2021 - $<span id="xdx_90A_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember_z6NIde61G83j" title="Accounts receivable, after allowance for credit loss">4,940,995</span> or <span id="xdx_90C_ecustom--ConcentrationRiskThresholdPercentage_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zkW2vXSnAjQg" title="Accounts receivable, after allowance for credit loss, percentage">69</span>%).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The credit risk on cash is limited because the Company limits its exposure to credit loss by placing its cash with major financial institutions. The Company maintains cash balances at financial institutions which at times exceed federally insured amounts. The Company has not experienced any losses in such accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is exposed to foreign exchange and interest rate risk to the extent that market value rate fluctuations materially differ from financial assets and liabilities, subject to fixed long-term rates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In order to manage its exposure to foreign exchange risks, the Company is closely monitoring the fluctuations in the foreign currency exchange rates and the impact on the value of cash, accounts receivable, and accounts payable and accrued liabilities. The Company has not hedged its exposure to currency fluctuations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is exposed to interest rate risk to the extent that the fair value or future cash flows for financial liabilities will fluctuate as a result of changes in market interest rates. The Company is exposed to interest rate risk on its long-term debt.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In order to manage its exposure to interest rate risk, the Company is closely monitoring fluctuations in market interest risks and will refinance its long-term debt where possible to obtain more favourable rates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_846_eus-gaap--UseOfEstimates_zrumup7AyQik" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m) <i><span id="xdx_86C_z8sTHA7m8L2l">Use of Estimates</span></i>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and would impact the results of operations and cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimates and underlying assumptions are reviewed at each period end. Revisions to accounting estimates are recognized in the period in which the estimates are revised and in any future periods affected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant areas requiring the use of management estimates include assumptions and estimates relating to the valuation of goodwill and intangible assets, share-based payments, valuation allowances for deferred income tax assets, determination of useful lives of property, equipment and leaseholds and intangible assets, recoverability of accounts receivable, recoverability of investments and the valuation of inventory.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.055 pure
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
483113 usd
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
265846 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
217267 usd
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
50045 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
167222 usd
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
483113 usd
CY2021 FSI Lease Interest Expense
LeaseInterestExpense
22057 usd
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
287903 usd
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
217267 usd
CY2022 FSI Lease Interest Expense
LeaseInterestExpense
8566 usd
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
58611 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
167222 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
58080 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
109142 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
167222 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
58080 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
59520 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
61020 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
178620 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
11398 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
167222 usd
CY2022Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
9739150 usd
CY2021Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
7403308 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
289293 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
273979 usd
CY2022Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
9449857 usd
CY2021Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
7129329 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
194380 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3806646 usd
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3417829 usd
CY2022Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
10612784 usd
CY2021Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
6084176 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
14419430 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
9502005 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
18399675 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8690387 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9709288 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
12538418 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7606705 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4931713 usd
CY2022 us-gaap Depreciation
Depreciation
1103732 usd
CY2021 us-gaap Depreciation
Depreciation
773497 usd
CY2021Q1 us-gaap Area Of Land
AreaOfLand
3.3 sqft
CY2022Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
195725 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
195725 usd
CY2021Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
208079 usd
CY2022Q4 FSI Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Long Term Debt
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt
-2849500 usd
CY2022Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
883248 usd
CY2022Q4 FSI Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Less Purchase Price
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLessPurchasePrice
376589 usd
CY2022 FSI Investment Eliminated Upon Consolidation
InvestmentEliminatedUponConsolidation
-41538 usd
CY2022 FSI Gain On Acquisition Of Subsidiary
GainOnAcquisitionOfSubsidiary
335051 usd
CY2021 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2023-12-06
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
13699 usd
CY2022Q4 FSI Increase In Currency Conversion
IncreaseInCurrencyConversion
265102 cad
CY2021Q4 FSI Increase In Currency Conversion
IncreaseInCurrencyConversion
265102 cad
CY2021Q4 us-gaap Goodwill
Goodwill
2534275 usd
CY2022Q4 us-gaap Goodwill
Goodwill
2534275 usd
CY2021Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
770000 usd
CY2022Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
770000 usd
CY2022Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
8540 usd
CY2021Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
8540 usd
CY2022 us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
506659 usd
CY2022Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
7330 usd
CY2022Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Buildings
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings
3750000 usd
CY2022Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Land
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand
150000 usd
CY2022Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
174582 usd
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
2366598 usd
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
3847638 usd
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
2366598 usd
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
3847638 usd
CY2022 us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
3230798 usd
CY2022 FSI Proceeds From Loan Acquired From Acquisition
ProceedsFromLoanAcquiredFromAcquisition
2849500 usd
CY2021 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
537960 usd
CY2022 us-gaap Payments For Proceeds From Deposit On Loan
PaymentsForProceedsFromDepositOnLoan
2292819 usd
CY2021 us-gaap Payments For Proceeds From Deposit On Loan
PaymentsForProceedsFromDepositOnLoan
943080 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
6154077 usd
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
2366598 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
6154077 usd
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
2366598 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
717612 usd
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
793574 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5436465 usd
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1573024 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
1017059 usd
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
1309503 usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
460098 usd
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
592394 usd
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
216082 usd
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
91285 usd
CY2022 FSI Current Tax
CurrentTax
1693239 usd
CY2021 FSI Current Tax
CurrentTax
1993182 usd
CY2022 FSI Income Tax Recovery
IncomeTaxRecovery
-1476088 usd
CY2022 FSI Current Income Tax Expense Benefits
CurrentIncomeTaxExpenseBenefits
217151 usd
CY2021 FSI Current Income Tax Expense Benefits
CurrentIncomeTaxExpenseBenefits
1993182 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-49088 usd
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
250153 usd
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-22207 usd
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
113164 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-71295 usd
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
363317 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
145856 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2356499 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7859085 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6650756 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.3050 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.3050 pure
CY2022 FSI Expected Income Tax Recovery
ExpectedIncomeTaxRecovery
2397021 usd
CY2021 FSI Expected Income Tax Recovery
ExpectedIncomeTaxRecovery
2028481 usd
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
-243167 usd
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
-29508 usd
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-2004041 usd
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-65027 usd
CY2021 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
337961 usd
CY2022 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-226611 usd
CY2021 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-86696 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
222654 usd
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-171288 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
145856 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2356499 usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
217151 usd
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1993182 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-71295 usd
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
363317 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
145856 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2356499 usd
CY2022 FSI Current Income Tax Expense
CurrentIncomeTaxExpense
1476088 usd
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
3878060 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
7021604 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
3449162 usd
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12379316 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12316254 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12466415 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12505522 shares
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.57
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.28
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.28
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1304000 shares
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
21000 shares
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
1 pure
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P5Y
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
749000 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.42
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
170000 shares
CY2021 FSI Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Granted Options Exercise Price
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeGrantedOptionsExercisePrice
3.61
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.61
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
34799 shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
2.30
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
94701 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.58
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
789500 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.78
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
981000 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.55
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
13486 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
2.32
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
71014 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.98
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1686000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.26
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
680000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.92
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y10M24D
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0123 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.6328 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.23
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1432960 usd
CY2022 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3M27D
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
45840469 usd
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34416335 usd
CY2022Q4 us-gaap Noncurrent Assets
NoncurrentAssets
14850786 usd
CY2021Q4 us-gaap Noncurrent Assets
NoncurrentAssets
10296954 usd

Files In Submission

Name View Source Status
0001493152-23-010222-index-headers.html Edgar Link pending
0001493152-23-010222-index.html Edgar Link pending
0001493152-23-010222.txt Edgar Link pending
0001493152-23-010222-xbrl.zip Edgar Link pending
audit_001.jpg Edgar Link pending
audit_002.jpg Edgar Link pending
ex23-1.htm Edgar Link pending
ex23-1_001.jpg Edgar Link pending
ex23-1_002.jpg Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
fsi-20221231.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
fsi-20221231_def.xml Edgar Link unprocessable
fsi-20221231_lab.xml Edgar Link unprocessable
fsi-20221231_pre.xml Edgar Link unprocessable
form10-k_htm.xml Edgar Link completed
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
fsi-20221231_cal.xml Edgar Link unprocessable